Analysis of resistance mechanisms to ALK kinase inhibitors in ALK+ NSCLC patients.
Robert Charles Doebele
Honoraria - Abbott Laboratories; Pfizer
Research Funding - ImClone Systems; Lilly; Pfizer
Dara L Aisner
Honoraria - GlaxoSmithKline; Pfizer
Anh T Le
No relevant relationships to disclose
Eamon M Berge
No relevant relationships to disclose
Amanda B. Pilling
No relevant relationships to disclose
Tatiana G. Kutateladze
No relevant relationships to disclose
Andrew James Weickhardt
Honoraria - Pfizer
Wilbur A. Franklin
No relevant relationships to disclose
Marileila Varella-Garcia
Honoraria - Abbott Molecular
D. Ross Camidge
Consultant or Advisory Role - ARIAD; Chugai Pharma; Novartis; Pfizer
Honoraria - Pfizer